Overview

Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Nitisinone 10 mg Tablets (Test Product 1 (TP1)) and Nitisinone 10 mg Tablets High Compritol (Test Product 2 (TP2)) are bioequivalent to the reference product Orfadin 10 mg capsules.
Phase:
Phase 1
Details
Lead Sponsor:
Cycle Pharmaceuticals Ltd.
Collaborator:
Parexel
Treatments:
Nitisinone